<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Nakamura S</submitter><funding>JSPS KAKENHI</funding><funding>Japan Agency for Medical Research and Development</funding><funding>Japan Agency for Medical Research and Development (AMED)</funding><pagination>16</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10978965</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(1)</volume><pubmed_abstract>Osteogenesis imperfecta is characterized by frequent fractures, bone deformities, and other systemic symptoms. Severe osteogenesis imperfecta may progress to hydrocephalus; however, treatment strategies for this complication remain unclear. Here, we describe severe osteogenesis imperfecta in an infant with symptomatic hydrocephalus treated with ventriculosubgaleal shunt placement. Targeted next-generation sequencing revealed novel compound heterozygous CRTAP variants, i.e., NM_006371.5, c.241 G > T, p.(Glu81*) and NM_006371.5, c.923-2_932del. We suggest that ventriculosubgaleal shunt placement is an effective and safe treatment for hydrocephalus in patients with severe osteogenesis imperfecta.</pubmed_abstract><journal>Human genome variation</journal><pubmed_title>Ventriculosubgaleal shunt placement for hydrocephalus in osteogenesis imperfecta with novel compound heterozygous CRTAP variants.</pubmed_title><pmcid>PMC10978965</pmcid><funding_grant_id>JP22ek0109493</funding_grant_id><pubmed_authors>Inoue T</pubmed_authors><pubmed_authors>Tanaka H</pubmed_authors><pubmed_authors>Okada K</pubmed_authors><pubmed_authors>Kato M</pubmed_authors><pubmed_authors>Takami H</pubmed_authors><pubmed_authors>Takahashi N</pubmed_authors><pubmed_authors>Ibi K</pubmed_authors><pubmed_authors>Takasugi N</pubmed_authors><pubmed_authors>Nakamura S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ventriculosubgaleal shunt placement for hydrocephalus in osteogenesis imperfecta with novel compound heterozygous CRTAP variants.</name><description>Osteogenesis imperfecta is characterized by frequent fractures, bone deformities, and other systemic symptoms. Severe osteogenesis imperfecta may progress to hydrocephalus; however, treatment strategies for this complication remain unclear. Here, we describe severe osteogenesis imperfecta in an infant with symptomatic hydrocephalus treated with ventriculosubgaleal shunt placement. Targeted next-generation sequencing revealed novel compound heterozygous CRTAP variants, i.e., NM_006371.5, c.241 G > T, p.(Glu81*) and NM_006371.5, c.923-2_932del. We suggest that ventriculosubgaleal shunt placement is an effective and safe treatment for hydrocephalus in patients with severe osteogenesis imperfecta.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-21T21:28:49.826Z</modification><creation>2025-04-05T18:25:12.304Z</creation></dates><accession>S-EPMC10978965</accession><cross_references><pubmed>38548746</pubmed><doi>10.1038/s41439-024-00274-z</doi></cross_references></HashMap>